Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants
Jean Kwun, Jie Li, Clay Rouse, Jae Berm Park, Alton B. Farris, Maragatha Kuchibhatla, Joseph W. Turek, Stuart J. Knechtle, Allan D. Kirk, M. Louise Markert
Jean Kwun, Jie Li, Clay Rouse, Jae Berm Park, Alton B. Farris, Maragatha Kuchibhatla, Joseph W. Turek, Stuart J. Knechtle, Allan D. Kirk, M. Louise Markert
View: Text | PDF
Research Article Immunology Transplantation

Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants

  • Text
  • PDF
Abstract

Eighty-six infants born without a thymus have been treated with allogeneic cultured thymus tissue implantation (CTTI). These infants, who lack T cells and are profoundly immunodeficient at birth, after CTTI from an unmatched donor develop T cells similar to those of recipient that are tolerant to both their own major histocompatibility antigens and those of the donor. We tested use of CTTI with the goal of inducing tolerance to unmatched heart transplants in immunocompetent rats. We thymectomized and T cell–depleted Lewis rats. The rats were then given cultured thymus tissue from F1 (Lewis × Dark Agouti ) under the kidney capsule and vascularized Dark Agouti (DA) heart transplants in the abdomen. Cyclosporine was administered for 4 months. The control group did not receive CTTI. Recipients with CTTI showed repopulation of naive and recent thymic emigrant CD4 T cells; controls had none. Recipients of CTTI did not reject DA cardiac allografts. Control animals did not reject DA grafts, due to lack of functional T cells. To confirm donor-specific unresponsiveness, MHC-mismatched Brown Norway (BN) hearts were transplanted 6 months after the initial DA heart transplant. LW rats with LWxDA CTTI rejected the third-party BN hearts (mean survival time 10 days); controls did not. CTTI recipients produced antibody against third-party BN donor but not against the DA thymus donor, demonstrating humoral donor-specific tolerance. Taken together, F1(LWxDA) CTTI given to Lewis rats resulted in specific tolerance to the allogeneic DA MHC expressed in the donor thymus, with resulting long-term survival of DA heart transplants after withdrawal of all immunosuppression.

Authors

Jean Kwun, Jie Li, Clay Rouse, Jae Berm Park, Alton B. Farris, Maragatha Kuchibhatla, Joseph W. Turek, Stuart J. Knechtle, Allan D. Kirk, M. Louise Markert

×

Figure 4

T cell infiltration (CD3 IHC) in LW, DA, and BN hearts.

Options: View larger image (or click on image) Download as PowerPoint
T cell infiltration (CD3 IHC) in LW, DA, and BN hearts.
(A) Quantificati...
(A) Quantification of inflammatory cells in the primary abdominal DA cardiac allograft. DA grafts from animals both with and without CTTI showed no significantly reduced inflammatory cell infiltration (at POD180) compared with DA control grafts (in LW rats with no immunosuppression), showing a high level of graft infiltration of immune cells. (B) Quantification of inflammatory cells in secondary cervical BN cardiac allografts. Both the BN control grafts (in LW rats with no immunosuppression) and the BN grafts from recipients with CTTI showed significantly elevated inflammatory cell infiltration. The BN grafts from animals without CTTI showed significantly reduced inflammatory cell infiltration compared with BN control. (C) Heart allografts from DA and BN rats were harvested with native heart at the time of BN heart rejection. Grossly, native heart and DA heart (POD 196) did not show a dramatic increase of T cells, whereas BN heart (POD14) showed a massive amount of T cells in recipients with CTTI. Images were adapted from whole slide scan. For panels A and B, 3–5 animals per group were analyzed; Turkey test, *P < 0.05; **P< 0.01; ***P < 0.001; NS, not significant (P > 0.05). LW, Lewis; DA, Dark Agouti; BN, Brown Norway; CTTI, cultured thymus tissue implantation.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts